# US 2025/0084100 A1 · Method for preparing nitrogen-containing polycyclic fused ring compound, and intermediate and use of compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084100 A1
- Document ID: US20250084100A1
- Status: Published application
- Kind: A1
- Application number: 18/577,791
- Filed: 2022-07-01
- Published: 2025-03-13
- Earliest claimed: 2021-07-09
- Assignees: Applied Pharmaceutical Science, Inc.
- Applicants: Applied Pharmaceutical Science, Inc.
- Inventors: Jun ZHONG; Qin GAO; Minchun CHEN; Yongbo LIU; Hao WANG
- Web page: https://patentgrep.com/patent/US20250084100A1

## CPC

- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D 471/04: Ortho-condensed systems
- C07D 471/14: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A method for preparing a nitrogen-containing polycyclic fused ring compound of formula I, and an intermediate thereof are provided. By this method, the compound of formula I can be produced on an industrial scale without column chromatography separation, purification steps such as silica gel column chromatography, or hydrogen. In addition, the preparation method effectively uses positional isomers IIIA and IIIB, and improves the yield of a target product from being adversely influenced by discarding positional isomer IIIA.

## Claims

### Claim at position 1

1-45. (canceled)

### Claim 46

A preparation method M1A for a compound of formula I, wherein the preparation method comprises reacting a compound of formula XX with Rk—C(O)—H to give the compound of formula I:
wherein,
X1, X2, X3, and X4 are identical or different, and are each independently selected from CR1 or N;
each R1 is identical or different, and is independently selected from H, halogen, CN, OH, and the following groups unsubstituted or optionally substituted with one, two or more Ra: C1-40 alkyl, C3-40 cycloalkyl, C1-40 alkyloxy, C3-40 cycloalkyloxy, NR2R3, —C(O)R4, —OCR5, —S(O)2R6, and OS(O)2R7;
D and E are identical or different, and are each independently selected from H, halogen, CN, OH, —O—R21, and the following groups unsubstituted or optionally substituted with one, two or more Rc: C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, and NR2R3, provided that at least one of D and E is selected from —O—R21;
R21 is selected from the following groups unsubstituted or optionally substituted with one, two or more Rd: C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, and 3- to 20-membered heterocyclyl;
G is selected from the following groups unsubstituted or optionally substituted with one, two or more Re: C3-40 cycloalkyl, C3-40 cycloalkenyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C3-40 cycloalkyloxy, C3-40 cycloalkenyloxy, C6-20 aryloxy, 5- to 20-membered heteroaryloxy, and 3- to 20-membered heterocyclyloxy;
Rk is selected from the following groups unsubstituted or optionally substituted with one, two or more Rg: C1-40 alkyl, C3-40 cycloalkyl, C3-40 cycloalkenyl, C6-20 aryl, 5- to 20-membered heteroaryl, and 3- to 20-membered heterocyclyl;
each R2 is identical or different, and is independently selected from H, C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, —C(O)R4, and —S(O)2R6;
each R3 is identical or different, and is independently selected from H, C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, —C(O)R4, and —S(O)2R6;
or, R2 and R3, together with the N atom connected thereto, form 5- to 20-membered heteroaryl or 3- to 20-membered heterocyclyl;
each R4 is identical or different, and is independently selected from H, C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C1-40 alkyloxy, C3-40 cycloalkyloxy, C6-20 aryloxy, 5- to 20-membered heteroaryloxy, 3- to 20-membered heterocyclyloxy, and NR2R3;
each R5 is identical or different, and is independently selected from H, C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C1-40 alkylcarbonyl, C3-40 cycloalkylcarbonyl, C6-20 arylcarbonyl, 5- to 20-membered heteroarylcarbonyl, and 3- to 20-membered heterocyclylcarbonyl;
each R6 is identical or different, and is independently selected from H, C1-40 alkyl, C2-40 alkenyl, C2-40 alkynyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C1-40 alkyloxy, C3-40 cycloalkyloxy, C6-20 aryloxy, 5- to 20-membered heteroaryloxy, 3- to 20-membered heterocyclyloxy, and NR2R3;
each R7 is identical or different, and is independently selected from H, C1-40 alkyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, and 3- to 20-membered heterocyclyl;
each Ra, Rc, Rd and Re are identical or different, and are independently selected from halogen, CN, OH, SH, oxo (═O), NO2, and the following groups unsubstituted or optionally substituted with one, two or more Rg: C1-40 alkyl, C2-40 alkenyl, C2-40 alkynyl, C3-40 cycloalkyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C1-40 alkyloxy, C3-40 cycloalkyloxy, C6-20 aryloxy, 5- to 20-membered heteroaryloxy, and 3- to 20-membered heterocyclyloxy;
each Rg is identical or different, and is independently selected from halogen, CN, OH, SH, oxo (═O), NO2, and the following groups unsubstituted or optionally substituted with one, two or more Rh: C1-40 alkyl, C2-40 alkenyl, C2-40 alkynyl, C3-40 cycloalkyl, C3-40 cycloalkenyl, C3-40 cycloalkynyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C1-40 alkyloxy, C2-40 alkenyloxy, C2-40 alkynyloxy, C3-40 cycloalkyloxy, C3-40 cycloalkenyloxy, C3-40 cycloalkynyloxy, C6-20 aryloxy, 5- to 20-membered heteroaryloxy, and 3- to 20-membered heterocyclyloxy;
each Rh is identical or different, and is independently selected from halogen, CN, OH, SH, oxo (═O), NO2, and the following groups unsubstituted or optionally substituted with one, two or more Rg: C1-40 alkyl, C2-40 alkenyl, C2-40 alkynyl, C3-40 cycloalkyl, C3-40 cycloalkenyl, C3-40 cycloalkynyl, C6-20 aryl, 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, C1-40 alkyloxy, C2-40 alkenyloxy, C2-40 alkynyloxy, C3-40 cycloalkyloxy, C3-40 cycloalkenyloxy, C3-40 cycloalkynyloxy, C6-20 aryloxy, 5- to 20-membered heteroaryloxy, and 3- to 20-membered heterocyclyloxy;
or, where the C3-40 cycloalkyl, C3-40 cycloalkenyl, C3-40 cycloalkynyl or 3- to 20-membered heterocyclyl described above is substituted with two or more substituents at different positions, any two of the substituents may also, together with the atom connected thereto, form a bridged ring, wherein the bridge atoms other than the bridgehead atoms in the bridged ring may comprise 1, 2, 3, 4, or 5 divalent groups selected from CH2, O, and NH;
or, where one atom (such as carbon atom) is substituted with two or more substituents, two of the substituents may also, together with the shared atom connected thereto, form a cyclic group such as C3-40 cycloalkyl, C3-40 cycloalkenyl, C3-40 cycloalkynyl, 3- to 20-membered heterocyclyl, or the like;
preferably,
X1, X2, X3, and X4 are identical or different, and are each independently selected from CR1 or N;
for example, at least one of X1, X2, X3, and X4 is N, e.g., one, two or three of X1, X2, X3, and X4 are N;
each R1 is identical or different, and is independently selected from H, halogen, CN, OH, and the following groups unsubstituted or optionally substituted with one, two or more Ra: C1-6 alkyl, C3-10 cycloalkyl, C1-6 alkyloxy, and C3-10 cycloalkyloxy, for example, selected from the following group unsubstituted or optionally substituted with 1, 2 or 3 Ra: C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkoxy, or C3-6 cycloalkyloxy;
D and E are identical or different, and are each independently selected from H, halogen, CN, NH2, C1-6 alkyl, or —O—R21, provided that at least one of D and E is selected from —O—R21;
preferably, at least one of D and E is selected from the following group:
preferably, R2 is selected from C1-6 alkyl unsubstituted or optionally substituted with one, two or more Rd;
preferably, each Ra, Rc and Rd are identical or different, and are independently selected from halogen, CN, OH, and the following groups unsubstituted or optionally substituted with one, two or more Rg: C1-6 alkyl, C1-6 alkyloxy, C3-10 cycloalkyl, and C3-10 cycloalkyloxy;
preferably, each Rg is identical or different, and is independently selected from halogen or C3-10 cycloalkyl;
preferably, G is selected from C3-10 cycloalkyl, C6-14 aryl, 5- to 14-membered heteroaryl, and 3- to 10-membered heterocyclyl, for example, 6- to 7-membered heterocyclyl having a monocyclic, bicyclic or bridged ring structure containing 1, 2 or 3 heteroatoms independently selected from N, O, and S;
preferably, Rk is selected from the following groups unsubstituted or optionally substituted with one, two or more Rg: C3-10 cycloalkyl, C6-14 aryl, 5- to 14-membered heteroaryl, and 3- to 10-membered heterocyclyl, wherein the heteroaryl may be pyridinyl, for example, selected from pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridin-5-yl, and pyridin-6-yl; the aryl may be phenyl;
preferably, X1, X2, X3, and X4 are identical or different, and are each independently selected from CH or N; for example, at least one of X1, X2, X3, and X4 is N, e.g., one, two or three of X1, X2, X3, and X4 are N;
preferably, R1 is H;
preferably, E is H;
preferably, D is selected from the following groups: halogen, BnO—, H, —CN, —NH2, —OCH3, and the following groups:
preferably, G is selected from
preferably, Rk is selected from pyridinyl or phenyl unsubstituted or optionally substituted with one, two or more R9, wherein where one, two or more R9 substituents are present, the R9 may be a substituent at position 1, 2, 3, 4, 5 or 6 of the pyridinyl or phenyl, as long as it does not affect the connection of Rk to group G via methylene;
preferably, Rk in the compound of formula I may, together with methylene, form a group selected from the following:
or Rk in the compound of formula I may be selected from group
substituted with 1, 2, 3 or 4 groups selected from C1-6 alkyl and C1-6 alkyloxy;
preferably, the starting material, reaction product or intermediate is not separated or purified using chromatography such as column chromatography; and/or
the reaction is carried out without using hydrogen as a hydrogenation or reduction reagent, and without using hydrogen by means of catalytic hydrogenation.

### Claim 47 (depends on 46)

The preparation method MIA according to claim 46, wherein the compound of formula I is selected from the following compounds:

### Claim 48 (depends on 46)

The preparation method M1A according to claim 46, wherein,
the reaction of the compound of formula XX with Rk—C(O)—H may be carried out in the presence of borane, pyridine borane, 2-picoline borane (Pic-BH3), sodium borohydride, sodium triacetoxyborohydride, or sodium cyanoborohydride, preferably in the presence of 2-picoline borane and a base;
the molar ratio of the compound of formula XX to Rk—C(O)—H may be 1:1 to 1:5, preferably 1:1.1 to 1:1.3;
the molar ratio of the compound of formula XX to borane or 2-picoline borane may be 1:1 to 1:5, preferably 1:1.1 to 1:1.3;
the molar ratio of the compound of formula XX to the base may be 1:1 to 1:5, preferably 1:1.5 to 1:3.5, such as 1:1.8 to 1:2.2;
the reaction in the preparation method for the compound of formula I may be carried out at a temperature of 15-50° C., for example, 20-30° C., such as room temperature;
preferably,
the preparation method M1A comprises subjecting compound 20 to the following reaction to prepare compound 1:

### Claim 49 (depends on 46)

A preparation method M20 for the compound of formula XX, comprising reacting a compound of formula XIX under a condition where PG19 is removed to give the compound of formula XX:
wherein,
G is selected from the following groups unsubstituted or optionally substituted with one, two or more Re: 5- to 20-membered heteroaryl, 3- to 20-membered heterocyclyl, 5- to 20-membered heteroaryloxy, or 3- to 20-membered heterocyclyloxy, wherein G has at least 1 N atom, and the N atom is connected to PG19;
X1, X2, X3, X4, D, E, and Re are independently defined as in claim 46;
PG19 is an amino protecting group, for example, PG19 may be selected from tert-butoxycarbonyl (Boc), cyclobutoxycarbonyl, benzyloxycarbonyl (CBz), p-methoxybenzylcarbonyl (Moz), 2-biphenyl-2-propoxycarbonyl (BPoc), 2,2,2-trichloroethoxycarbonyl (Troc), phthalimidyl, p-toluenesulfonyl, trifluoroacetyl, (9H-fluoren-9-ylmethoxy)carbonyl (Fmoc), benzyl, 4-methoxybenzyl, diphenylmethyl, 2-(trimethylsilyl)ethoxycarbonyl (Teoc), adamantyloxycarbonyl (Adoc), formyl, acetyl, and the like;
the condition where PG19 of the compound of formula XIX is removed may be, for example, a condition where PG19 group of the compound of formula XIX is removed in the presence of an acid, wherein the acid may be selected from one, two or more of inorganic acids or organic acids such as hydrochloric acid, sulfuric acid, formic acid, acetic acid, and the like;
preferably, in the preparation method for the compound of formula XX, the molar ratio of the compound of formula XIX to the acid may be 1:1 to 1:5, such as 1:3 to 1:4;
the reaction of the compound of formula XIX for removing PG19 may be carried out in the presence of an organic solvent, wherein the organic solvent may be, for example, an alcohol solvent, such as one, two or more selected from methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, and tert-butanol;
preferably, the reaction in the preparation method for the compound of formula I may be carried out at a temperature of 40-70° C., for example, 50-60° C.;
the compound of formula XX is defined as in claim 46;
preferably, wherein the preparation method comprises subjecting compound 19 to the following reaction to prepare compound 20:

### Claim 50 (depends on 49)

A preparation method M19A for the compound of formula XIX, comprising reacting a compound of formula XI with a compound of formula XVIII to give the compound of formula XIX:
wherein X1, X2, X3, X4, D, E, and G are independently defined as in claim 49;
L11 is selected from leaving groups, such as the following groups unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens: C1-6 alkylsulfonyloxy and C1-6 alkylbenzenesulfonyloxy (e.g., methanesulfonyloxy (MsO—), trifluoromethanesulfonyloxy (TfO—), and p-toluenesulfonyloxy (TsO—)), and halogen (e.g., F, Cl, Br, or I);
preferably, the reaction may be carried out at a temperature of not less than 50° C., for example, not less than 80° C., such as 85° C.;
preferably, the preparation method may be carried out in the presence of a catalyst, wherein the catalyst may be a palladium catalyst, such as Pd(dba)2, PdCl2, Pd(OAc)2, Pd(dppf)Cl2, Pd2(dba)3, PdCl2(CH3CN)2, Pd(PPh3)4, PdCl2(PPh3)2, Pd(t-Bu)3, PdCl2(PPh3)2·CH2Cl2, Pd(OAc)/PPh3, PdCl2[(Pet3)]2, Pd(DIPHOS)2, PdCl2(Bipy), [PdCl(Ph2PCH2PPh2)]2, PdCl2[P(o-Tol)3]2, Pd2(dba)3/P(o-Tol)3, Pd2(dba)/P(furanyl)3, PdCl2[P(furanyl)3]2, PdCl2(PMePh2)2, PdCl2[P(4-F-Ph)3]2, PdCl2[P(C6F6)3]2, PdCl2[P(2-COOH-Ph)(Ph)2]2, and PdCl2[P(4-COOH-Ph)(Ph)2]2;
preferably, the preparation method may be carried out in the presence of a base;
preferably, the molar ratio of the compound of formula XI to the compound of formula XVIII may be 1:1 to 1:2, for example, 1:1.1 to 1:1.3, such as 1:1.2 to 1:1.3;
preferably, the molar ratio of the compound of formula XI to the base may be 1:1 to 1:5, for example, 1:1.5 to 1:3.5, such as 1:1.8 to 1:2.2;
preferably, the molar ratio of the compound of formula XI to the catalyst may be 1:0.001 to 1:0.05, such as 1:0.02 to 1:0.03;
preferably, the preparation method M19A comprises subjecting compound 11 and compound 18 to the following reaction to prepare compound 19:

### Claim 51 (depends on 50)

A preparation method M11 for the compound of formula XI, comprising reacting a compound of formula X with hydrazine (e.g., hydrazine hydrate) to give the compound of formula XI:
wherein,
D, E, and L11 are independently defined as in claim 50;
L10 is selected from a leaving group, for example, halogen, such as F, Cl, Br, or I;
preferably, the reaction may be carried out at a temperature of not less than 100° C., such as 110-115° C.;
preferably, the molar ratio of the compound of formula X to hydrazine may be 1:1 to 1:15, for example, 1:2 to 1:10, such as 1:6 to 1:8;
preferably, the preparation method M11 comprises subjecting compound 10 to the following reaction to prepare compound 11:

### Claim 52 (depends on 51)

A preparation method M10A for the compound of formula X, comprising reacting a compound of formula XIII with a compound of R21-L13 to give the compound of formula X:
wherein,
R21, D, L10, and L11 are independently defined as in claim 51;
E is selected from —O—R21;
L13 is selected from leaving groups, for example, halogens, such as the following groups unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens: C1-6 alkylsulfonyloxy and C1-6 alkylbenzenesulfonyloxy (e.g., methanesulfonyloxy (MsO—), trifluoromethanesulfonyloxy (TfO—), and p-toluenesulfonyloxy (TsO—), and F, Cl, Br or I;
preferably, the molar ratio of the compound of formula XIII to the compound of R21-L13 may be 1:1 to 1:2, for example, 1:1 to 1:1.2, such as 1:1 to 1:1.1;
preferably, the reaction may be carried out at a temperature of not less than 50° C., for example, 60-70° C.;
preferably, the preparation method M10A comprises subjecting compound 13 to the following reaction to prepare compound 10:

### Claim 53 (depends on 52)

A preparation method M13 for the compound of formula XIII, comprising reacting a compound of formula IIIB in the presence of phosphorus oxychloride (POCl3), wherein the compound of formula IIIB has the following structure:
wherein,
L10 and L11 are independently defined as in claim 52;
PG3 is selected from hydroxyl protecting groups such as the following groups unsubstituted or optionally substituted with 1, 2, 3, 4 or 5 substituents selected from C1-6 alkyl, C1-6 alkyloxy and halogen: benzyl, C1-6 alkyl, tri(C1-6 alkyl)silyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, allyl, triphenylmethyl, C1-6 alkyloxymethyl, benzyloxymethyl, C1-6 alkylcarbonyl, C1-6 haloalkylcarbonyl, and benzoyl, for example, selected from benzyl, 4-methoxybenzyl, 4-methylbenzyl, 4-chlorobenzyl, 4-bromobenzyl, or 2,3,4-trimethoxybenzyl;
preferably, the preparation method M13 comprises reacting compound 3b in the presence of phosphorus oxychloride (POCl3), wherein compound 3b has the following structure:
preferably, the compound of formula IIIB may be first reacted with phosphorus oxychloride to give a compound of formula XII, and then the compound of formula XII is further reacted to give the compound of formula XIII, wherein the compound of formula XII has the following structure:
wherein L10, L11, and PG3 are independently defined as above;
preferably, the molar ratio of the compound of formula IIIB to phosphorus oxychloride may be 1:2 to 1:4, for example, 1:2 to 1:3, such as 1:2.4 to 1:2.5;
preferably, the preparation method for the compound of formula XIII may be carried out by a one-pot process;
preferably, a reaction solvent for the reaction of the compound of formula IIIB with phosphorus oxychloride to give the compound of formula XII may be an organic solvent, such as N,N-dimethylformamide;
preferably, the reaction of the compound of formula IIIB with phosphorus oxychloride to give the compound of formula XII may be carried out at a temperature of −5 to 80° C., for example, 0-70° C.;
preferably, the preparation method M13 comprises preparing compound 12 from compound 3b and preparing compound 13 from compound 12 by the following reaction:

### Claim 54 (depends on 51)

A preparation method M10B for the compound of formula X, comprising reacting a compound of formula XVII with phosphorus oxychloride to give the compound of formula X:
wherein D, E, L10, and L11 are independently defined as in claim 51;
preferably, the molar ratio of the compound of formula XVII to phosphorus oxychloride may be 1:2 to 1:8, for example, 1:3 to 1:6, such as 1:4 to 1:5;
preferably the preparation method M10B comprises subjecting compound 17 to the following reaction to prepare compound 10:

### Claim 55 (depends on 51)

A preparation method M17 for the compound of formula XVII, comprising reacting a compound of formula XVI with an alkali metal halide or an organic halide salt to give the compound of formula XVII:
wherein D, E, and L10 are independently defined as in claim 51;
L16 is the following group unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens: C1-6 alkylsulfonyl or C1-6 alkylbenzenesulfonyl, such as methanesulfonyl (Ms-), trifluoromethanesulfonyl (Tf-) or p-toluenesulfonyl (Ts-);
the alkali metal halide or the organic halide salt may be selected from, for example, at least one of LiBr, NaBr, KBr, CsBr, and Bu4NBr;
the molar ratio of the compound of formula XVI to the alkali metal halide or the organic halide salt may be 1:1 to 1:5, for example, 1:1 to 1:2;
the preparation method for the compound of formula XVII may be carried out in the presence of a catalyst, wherein the catalyst is, for example, chloro(pentamethylcyclopentadienyl)bis(triphenylphosphine)ruthenium(II), tris(acetonitrile)pentamethylcyclopentadienylruthenium(II) trifluoromethanesulfonate, pentamethylcyclopentadienyltris(acetonitrile)ruthenium(II) hexafluorophosphate, chloro(pentamethylcyclopentadienyl)ruthenium(II) (dimer), chloro(pentamethylcyclopentadienyl)ruthenium(I) (tetramer), tris(acetonitrile)tetramethylcyclopentadienylruthenium(II) trifluoromethanesulfonate, or dichloro(1,5-cyclooctadien)ruthenium(II);
according to an embodiment of the present disclosure, in the preparation method for the compound of formula XVII, the molar ratio of the compound of formula XVI to the catalyst may be 1:0.01 to 1:0.1;
according to an embodiment of the present disclosure, the reaction in the preparation method for the compound of formula XVII may be carried out at a temperature of not less than 50° C., for example, not less than 80° C., such as 90-100° C.;
preferably, the preparation method M17 comprises subjecting compound 16 to the following reaction to prepare compound 17:

### Claim 56 (depends on 51)

A preparation method M16 for the compound of formula XVI, comprising reacting a compound of formula XV with a sulfonylation reagent to give the compound of formula XVI:
wherein D, E, and L10 are independently defined as in claim 51;
the sulfonylation reagent may be selected from one of C1-6 alkylsulfonyl chloride unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens, C1-6 alkylsulfonic anhydride unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens, and C1-6 alkylbenzenesulfonyl chloride unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens, such as methanesulfonyl chloride, methanesulfonic anhydride, trifluoromethanesulfonyl chloride, trifluoromethanesulfonic anhydride, p-toluenesulfonyl chloride, p-toluenesulfonic anhydride, and 1,1,1-trifluoro-N-phenyl-N-((trifluoromethyl)sulfonyl)methanesulfonamide (PhN(Tf)2);
preferably, the molar ratio of the compound of formula XV to the sulfonylation reagent may be 1:1 to 1:5, for example, 1:1 to 1:1.2, such as 1:1.1 to 1:1.15;
preferably, the preparation method M16 comprises subjecting compound 15 to the following reaction to prepare compound 16:

### Claim 57

A preparation method M15 for the compound of formula XV, comprising reacting a compound of formula XIV with an acid to give the compound of formula XV:
wherein D and E are independently defined as above;
L10 and PG3 are independently defined as above;
preferably, the acid may be selected from at least one of organic acids or inorganic acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphoric acid, sulfuric acid, methanesulfonic acid, trifluoromethanesulfonic acid, trimethylsilyl trifluoromethanesulfonate, trifluoroacetic acid, phosphorus oxychloride, succinic acid, and ascorbic acid;
preferably, the molar ratio of the compound of formula XIV to trifluoroacetic acid may be 1:1 to 1:10, for example, 1:4 to 1:6, such as 1:5 to 1:5.5.
preferably, the preparation method M15 comprises subjecting compound 14 to the following reaction to prepare compound 15:

### Claim 58

A preparation method M14 for the compound of formula XIV, comprising reacting a compound of formula IIIA with ethanol to give the compound of formula XIV:
wherein D is defined as above;
L10 and PG3 are independently defined as above;
L3a is selected from a leaving group, for example, halogen, such as chlorine, bromine, or iodine;
preferably, the preparation method for the compound of formula XIV may be carried out in the presence of a copper(I) catalyst or a copper(I) catalyst with a ligand; the copper catalyst may be selected from at least one of copper(I) iodide (CuI), copper(I) bromide (CuBr), and copper(II) acetylacetonate (Cu(acac)2);
preferably, the ligand may be selected from at least one of N1,N2-bis(4-hydroxy-2,6-dimethylphenyl)oxamide, 8-hydroxyquinoline, N,N-bis(2,4,6-trimethoxyphenyl)oxamide, N-benzyl-N-(2-methylnaphthalen-1-yl)oxamide, and N1,N2-bis(4-hydroxy-2,6-dimethylphenyl)oxamide;
preferably, the molar volume ratio of the compound of formula IIIA to ethanol may be 1 mol:(2-5) L, such as 1 mol:(3-4) L;
preferably, the molar ratio of the compound of formula IIIA to the copper(I) catalyst may be 1:0.01 to 1:0.2;
preferably, the molar ratio of the compound of formula IIIA to the base may be 1:1 to 1:10, such as 1:2 to 1:4;
preferably, the molar ratio of the compound of formula IIIA to the ligand may be 1:0.01 to 1:0.2, such as 1:0.02;
preferably, the reaction may be carried out at a temperature of not less than 50° C., for example, not less than 70° C., such as 80 to 100° C.;
preferably, the preparation method M14 comprises subjecting compound 3a to the following reaction to prepare compound 14:

### Claim 59 (depends on 58)

A preparation method for a compound of formula XXIII, comprising reacting the compound of formula IV with trifluoroacetic acid to give the compound of formula XXIII shown below:
wherein D, L10, and L3a are independently defined as in claim 58.

### Claim 60 (depends on 58)

A preparation method for a compound of formula XXXI, comprising reacting the compound of formula XXIII with hydrazine (e.g., hydrazine hydrate) to give the compound of formula XXXI shown below:
wherein D and L3a are independently defined as in claim 58.
